Remnant cholesterol predicts the development of type 2 diabetes mellitus in patients with established coronary artery disease

被引：0
|
作者：
Saely, C. [1 ,2 ,3 ]
Rein, P. [1 ]
Leiherer, A. [2 ,3 ]
Vonbank, A. [1 ,2 ]
Mader, A. [1 ,3 ]
Schuler, A. [1 ,2 ]
Ebner, K. -M. [1 ,2 ]
Zanolin, D. [2 ,3 ]
Drexel, H. [1 ,2 ,3 ,4 ]
机构：
[1] Acad Teaching Hosp Feldkirch, Dept Med & Cardiol, Feldkirch, Austria
[2] Vorarlberg Inst Vasc Invest & Treatment, Feldkirch, Austria
[3] Private Univ Principal Liechtenstein, Triesen, Liechtenstein
[4] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
来源：
WIENER KLINISCHE WOCHENSCHRIFT | 2016年 / 128卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P11
引用
收藏
页码：S382 / S382
页数：1
相关论文
共 50 条
  • [21] REMNANT CHOLESTEROL IN PATIENTS WITH ESTABLISHED ATHEROSCLEROTIC CORONARY ARTERY DISEASE. OUR EXPERIENCES
    Burazor, I.
    Otasevic, P.
    Tasic, N.
    Jakovljevic, V.
    Bojic, M.
    ATHEROSCLEROSIS, 2023, 379 : S180 - S180
  • [22] REMNANT CHOLESTEROL PREDICTS MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY ARTERY DISEASE BOTH AMONG PATIENTS WITH TYPE 2 DIABETES AND IN NON-DIABETIC INDIVIDUALS
    Mader, A.
    Sprenger, L.
    Vonbank, A.
    Larcher, B.
    Maechler, M.
    Leiherer, A.
    Plattner, T.
    Muendlein, A.
    Drexel, H.
    Saely, C.
    ATHEROSCLEROSIS, 2023, 379
  • [23] REMNANT CHOLESTEROL PREDICTS MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY ARTERY DISEASE BOTH AMONG PATIENTS WITH TYPE 2 DIABETES AND IN NON-DIABETIC INDIVIDUALS
    Mader, Arthur
    Sprenger, Lukas
    Vonbank, Alexander
    Larcher, Barbara
    Maechler, Maximilian
    Plattner, Thomas
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1707 - 1707
  • [24] Remnant cholesterol predicts major cardiovascular events in patients with coronary artery disease both among patients with type 2 diabetes and in non-diabetic individuals
    Mader, Arthur
    Sprenger, Lukas
    Vonbank, Alexander
    Larcher, Barbara
    Maechler, Maximilian
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (SUPPL 4) : 249 - 249
  • [25] Remnant cholesterol predicts major cardiovascular events in patients with coronary artery disease both among patients with Type 2 diabetes and in non-diabetic individuals
    Mader, A.
    Sprenger, L.
    Vonbank, A.
    Larcher, B.
    Maechler, M.
    Leiherer, A.
    Muendlein, A.
    Drexel, H.
    Saely, C. H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (SUPPL 2) : 205 - 205
  • [26] Silent coronary artery disease in patients with type 2 diabetes mellitus
    Gokcel, A
    Aydin, M
    Yalcin, F
    Yapar, AF
    Ertorer, ME
    Ozsahin, AK
    Muderrisoglu, H
    Aktas, A
    Guvener, N
    Akbaba, M
    ACTA DIABETOLOGICA, 2003, 40 (04) : 176 - 180
  • [27] Remnant Cholesterol in Patients with Established Cardiovascular Disease Predicts Cardiovascular Events Both among Patients with Type 2 Diabetes and among Nondiabetic Subjects
    Mader, Arthur
    Sprenger, Lukas
    Vonbank, Alexander
    Larcher, Barbara
    Maechler, Maximilian
    Mutschlechner, Beatrix
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    DIABETES, 2021, 70
  • [28] Silent coronary artery disease in patients with type 2 diabetes mellitus
    A. Gokcel
    M. Aydin
    F. Yalcin
    A. F. Yapar
    M. E. Ertorer
    A. K. Ozsahin
    H. Muderrisoglu
    A. Aktas
    N. Guvener
    M. Akbaba
    Acta Diabetologica, 2003, 40 : 176 - 180
  • [29] Management of coronary artery disease in patients with type 2 diabetes mellitus
    Srikanth S.
    Deedwania P.
    Current Cardiology Reports, 2007, 9 (4) : 264 - 271
  • [30] Remnant Cholesterol Predicts Major Cardiovascular Events in Coronary Artery Disease Patients with NAFLD
    Plattner, Thomas
    Larcher, Barbara
    Mader, Arthur
    Vonbank, Alexander
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    Saely, Christoph H.
    DIABETES, 2024, 73
12345